Table 2.
Diagnosis criteria for refractory chronic migraine accepted by the European Headache Federation (2014)
| 1: Chronic migraine—no overuse of medication |
| 2: Use of prophylactic medication in adequate doses for at least 3 months with each drug |
| 3: Lack of effect (or contraindications for use) of 2 to 4 drugs from each of the following groups after appropriate treatment# |
| A: β-blockers: propranolol, metoprolol, atenolol, bisoprolol |
| B: Anticonvulsants: sodium valproate, topiramate |
| C: Tricyclic antidepressants: amitriptyline |
| D: Others: flunarizine, candesartan |
| E: Botulinum toxin A |
| 4: Appropriate psychiatric treatment or other comorbidities carried out by a multidisciplinary group, if available |
Adapted from [38]
#Appropriate treatment is commonly understood as the time during which adequate doses of an indicated medication are administered, typically at least 2 months (preferably three) at the optimal dose or maximum tolerated dose, unless terminated earlier due to side effects. This concept requires the control of the factors promoting chronification [38, 39]